Abstract

The use of immunohistochemistry in the reporting of prostate biopsies is an important adjunct when the diagnosis is not definite on haematoxylin and eosin (H&E) morphology alone. The process is however inherently inefficient with delays while waiting for pathologist review to make the request and duplicated effort reviewing a case more than once. In this study, we aimed to capture the workflow implications of immunohistochemistry requests and demonstrate a novel artificial intelligence tool to identify cases in which immunohistochemistry (IHC) is required and generate an automated request. We conducted audits of the workflow for prostate biopsies in order to understand the potential implications of automated immunohistochemistry requesting and collected prospective cases to train a deep neural network algorithm to detect tissue regions that presented ambiguous morphology on whole slide images. These ambiguous foci were selected on the basis of the pathologist requesting immunohistochemistry to aid diagnosis. A gradient boosted trees classifier was then used to make a slide-level prediction based on the outputs of the neural network prediction. The algorithm was trained on annotations of 219 immunohistochemistry-requested and 80 control images, and tested by threefold cross-validation. Validation was conducted on a separate validation dataset of 222 images. Non IHC-requested cases were diagnosed in 17.9 min on average, while IHC-requested cases took 33.4 min over multiple reporting sessions. We estimated 11 min could be saved on average per case by automated IHC requesting, by removing duplication of effort. The tool attained 99% accuracy and 0.99 Area Under the Curve (AUC) on the test data. In the validation, the average agreement with pathologists was 0.81, with a mean AUC of 0.80. We demonstrate the proof-of-principle that an AI tool making automated immunohistochemistry requests could create a significantly leaner workflow and result in pathologist time savings.

Highlights

  • Prostate cancer (PCa) is the most common malignancy in men worldwide [1, 2] and biopsies with suspected prostate adenocarcinoma contribute a significant proportion of the workload for surgical pathology centres

  • We evaluate the potential implications of automating the pre-requesting by artificial intelligence (AI) of IHC in prostate biopsy cases that contain ill-defined epithelial morphology

  • Benign tissue and malignancies of the prostate present a large variety of morphological patterns, which pathologists must recognise by fitting the features to categories of recognised visual features and identifying distinctive characteristics of malignancy

Read more

Summary

Introduction

Prostate cancer (PCa) is the most common malignancy in men worldwide [1, 2] and biopsies with suspected prostate adenocarcinoma contribute a significant proportion of the workload for surgical pathology centres. The United Kingdom (UK) National Health Service (NHS) spends an estimated £27 million ($34 million) on locum and private services to cover this lack in service provision [3]. Over 60,000 prostate biopsies are carried out in the UK per year. [4] and over one million in the United States of America [5]. With some prostate biopsy cases being allocated over an hour for reporting under proposed workload guidelines, this represents a significant workload burden [6]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call